Want to see PCT full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.29Last Year’s EPS
-0.81Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed strong operational and commercial momentum: significant production scaling (Q1 production +12% vs. Q4; YoY production +95%), important customer qualifications with Procter & Gamble, the first CosPaTox highest‑purity milestone, an expanding pipeline (~180 opportunities) and completed capital/operational milestones (Ironton turnaround ahead of schedule and ~15% below budget). These positive developments are tempered by continued GAAP losses (Q1 net loss $33.4M), negative adjusted EBITDA (-$30.9M), a quarter‑over‑quarter liquidity decline (~28%), project development costs impacting near‑term profitability, and timing/regulatory dependencies (notably New Jersey) that could delay volume realization. On balance, operational improvements, commercial validations and available financing optionality outweigh the near‑term financial and timing headwinds, supporting a constructive outlook for the remainder of 2026.Company Guidance
Sequential Production and Throughput Growth
Ironton produced 8.4 million pounds of PureFive in Q1, up 12% vs. Q4, with ~10 million pounds of feedstock processed. Year-over-year production grew approximately 95%, demonstrating meaningful scaling of the technology and emerging operating leverage (monthly operations spending grew only ~6% YoY).
Revenue Momentum and Branded Sales
Reported revenue of $4.1 million in Q1 — the fifth consecutive quarter of sequential growth and above internal expectations — with a growing branded mix. The company converted 8 new customers in Q1 and noted branded applications representing 40–50 million pounds of annual demand starting to ramp in Q2–Q3 and an additional 20–25 million pounds in Q3–Q4.
Major Customer Qualifications and Quality Milestones
Achieved final commercialization approvals with Procter & Gamble for two applications (Tide caps shipping in Q2; Vicks ZzzQuil caps in H2 2026). Also achieved the highest CosPaTox purity grade (first recycler to do so), validating product quality for demanding cosmetic and detergent packaging uses.
Ironton Turnaround and Reliability Improvements
Completed the planned Ironton turnaround ahead of schedule and tracking ~15% below budget, executing >170 improvement projects focused on capacity, reliability and quality (including replacement of a critical seal system), expected to materially improve reliability and enable higher sustained run rates.
Compounding Capability and Third-Party Volumes
On-site compounding reached mechanical completion in April and is currently being commissioned; this strategically important capability will enable finished, application-ready products with better unit economics. Third‑party compounding volumes ramped to ~1.7 million pounds in Q1 with significant month-over-month growth.
Pipeline Expansion and International Traction
Active pipeline of ~180 opportunities (up from ~170 at year‑end and ~100 a year ago). Completed the first international sale (~300,000 pounds) and ongoing discussions to broaden relationships; trials with film producers (including Bruckner 6-meter lines) and multiple QSR/coffee‑lid opportunities advancing.
Favorable Macro and Regulatory Tailwinds
Macro disruptions increased virgin polypropylene pricing (U.S. +$0.25–$0.35/lb; Asia/Europe +$0.35–$0.55/lb) and HDPE roughly doubled (≈100% increase), improving co‑product pricing and strengthening demand for a stable domestic recycled supply. Regulatory momentum (California SB 54, New Jersey recycled content increases and food-contact deadlines) creates urgency among brands and converters.
Capital and Financing Optionality
Total liquidity of ~$131 million (cash $90M, marketable securities $31M, restricted $10M). Warrants extended to Mar 17, 2027 with reduced trigger price ($14.38) providing up to ~$273M potential proceeds. $200M revolving credit facility undrawn and ~$75M in revenue bonds available; equipment financing payments expected to step down in H2 2026.
Global Project Timelines and Grants
Thailand project on track for mechanical completion end of 2027 and production in 2028 with total expected investment ~ $250M; Belgium on track with ~€40M European Innovation Fund grant and expected investment ~ $350M. These projects expand global capacity and local supply capability.
PCT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PCT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | $7.62 | $8.94 | +17.32% |
Feb 26, 2026 | $8.12 | $6.31 | -22.29% |
Nov 06, 2025 | $9.61 | $10.54 | +9.68% |
Aug 07, 2025 | $12.35 | $12.35 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Purecycle Technologies Inc (PCT) report earnings?
Purecycle Technologies Inc (PCT) is schdueled to report earning on Aug 06, 2026, Before Open (Confirmed).
What is Purecycle Technologies Inc (PCT) earnings time?
Purecycle Technologies Inc (PCT) earnings time is at Aug 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PCT EPS forecast?
PCT EPS forecast for the fiscal quarter 2026 (Q2) is -0.29.